Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2008 2
2009 3
2010 1
2011 1
2012 1
2013 1
2014 3
2016 1
2018 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L, Yu J, Zhang S, Shan Y, Li Y, Xu L, Zhang J, Zhang J. Yang L, et al. J Ovarian Res. 2022 Feb 16;15(1):26. doi: 10.1186/s13048-022-00958-6. J Ovarian Res. 2022. PMID: 35168642 Free PMC article.
But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study aimed to construct and validate nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with ov …
But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study aime …
Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases.
Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S. Khunamornpong S, et al. Int J Gynecol Pathol. 2014 Mar;33(2):176-85. doi: 10.1097/PGP.0b013e318289452e. Int J Gynecol Pathol. 2014. PMID: 24487473
This study was aimed to evaluate the clinicopathologic details of primary ovarian mucinous adenocarcinoma and their prognostic significance. The clinicopathologic characteristics of 46 cases of mucinous adenocarcinoma were reviewed. ...The extent of infiltrative invasion i …
This study was aimed to evaluate the clinicopathologic details of primary ovarian mucinous adenocarcinoma and their prognostic signif …
Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.
Kim SK, Song SY, Kim S, Cho NH, Yim GW, Kim SW, Kim YT, Nam EJ. Kim SK, et al. Int J Clin Exp Pathol. 2014 Jul 15;7(8):5103-10. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25197383 Free PMC article.
After adjusting for various clinicopathologic parameters, PAUF positivity of MACs was a significant predictive factor for disease-free survival (DFS) (negative vs. weakly positive: P = 0.045, hazard ratio [HR] = 57.406, 95% confidence interval [CI]: 1.090-3022.596; and neg …
After adjusting for various clinicopathologic parameters, PAUF positivity of MACs was a significant predictive factor for disease-fre …
Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK, Soslow RA, Longacre TA. McKenney JK, et al. Am J Surg Pathol. 2008 May;32(5):645-55. doi: 10.1097/PAS.0b013e31815b486d. Am J Surg Pathol. 2008. PMID: 18344868
Pseudomyxoma ovarii is common in this setting, particularly in tumors with IM-LMP histology, but pseudomyxoma ovarii is not predictive of PMP. Ovarian teratoma-associated benign and IM-LMP mucinous neoplasms with microscopic peritoneal low-grade mucinous epithelium do not …
Pseudomyxoma ovarii is common in this setting, particularly in tumors with IM-LMP histology, but pseudomyxoma ovarii is not predictive …
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
Koh I, Hinoi T, Sentani K, Hirata E, Nosaka S, Niitsu H, Miguchi M, Adachi T, Yasui W, Ohdan H, Kudo Y. Koh I, et al. Cancer Med. 2016 Jul;5(7):1546-55. doi: 10.1002/cam4.697. Epub 2016 Apr 6. Cancer Med. 2016. PMID: 27060927 Free PMC article.
We hypothesized that profiling of CDX2 and MDR1 expression could be an effective strategy for predicting anticancer drug resistance. We studied the expression of these factors in clinical samples from ovarian cancer patients. ...
We hypothesized that profiling of CDX2 and MDR1 expression could be an effective strategy for predicting anticancer drug resistance. …
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.
Miura K, Ishida K, Fujibuchi W, Ito A, Niikura H, Ogawa H, Sasaki I. Miura K, et al. Surg Today. 2012 Jun;42(6):515-25. doi: 10.1007/s00595-012-0167-z. Epub 2012 Mar 23. Surg Today. 2012. PMID: 22441574 Review.
The treatments and prognoses of pelvic organ carcinomas differ, depending on whether the primary tumor originated in the rectum, urinary bladder, prostate, ovary, or uterus; therefore, it is essential to diagnose pathologically the primary origin and stages of these tumors …
The treatments and prognoses of pelvic organ carcinomas differ, depending on whether the primary tumor originated in the rectum, urin …
Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma.
Kong KY, Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Nam JH. Kong KY, et al. Ann Surg Oncol. 2011 Nov;18(12):3462-8. doi: 10.1245/s10434-011-1752-x. Epub 2011 May 10. Ann Surg Oncol. 2011. PMID: 21556953
The 5-year disease-free-survival rates in the IEC, IECMI, and MACEI groups were 97.7%, 77.3%, and 79.9%, respectively (IEC vs IECMI, P=0.004; IEC vs MACEI, P=0.012; IECMI vs MACEI, P=0.555). Prognosis was significantly poorer for patients with IECMI than for those with IEC …
The 5-year disease-free-survival rates in the IEC, IECMI, and MACEI groups were 97.7%, 77.3%, and 79.9%, respectively (IEC vs IECMI, P=0.004 …
CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY. Shin JH, et al. Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18. Jpn J Clin Oncol. 2010. PMID: 19926591
Obtaining the correct diagnosis is difficult but crucial to treatment and prognosis. METHODS: We evaluated the immunohistochemical (IHC) expression of cytokeratin 7 (CK7), cytokeratin 20 (CK20), CDX2, CEA, MUC2, MUC5AC and alpha-methylacyl-CoA racemase (AMACR) in 22 POMAs …
Obtaining the correct diagnosis is difficult but crucial to treatment and prognosis. METHODS: We evaluated the immunohistochemical (I …
Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Sato S, Itamochi H, Kigawa J, Oishi T, Shimada M, Sato S, Naniwa J, Uegaki K, Nonaka M, Terakawa N. Sato S, et al. Cancer Sci. 2009 Mar;100(3):546-51. doi: 10.1111/j.1349-7006.2008.01065.x. Epub 2008 Dec 19. Cancer Sci. 2009. PMID: 19154404 Free PMC article.
Resistance of ovarian mucinous adenocarcinoma to standard chemotherapy with paclitaxel and carboplatin is associated with poor prognosis, and an effective treatment is needed. The present study aimed to identify an effective chemotherapy for ovarian mucinous adenocarcinoma …
Resistance of ovarian mucinous adenocarcinoma to standard chemotherapy with paclitaxel and carboplatin is associated with poor prognosis …
15 results